Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shulman

Showing results (251-260 of 282) with videos related to

Pageof 29
Sort By:
JAMA Network Open|January 27, 2023
Peer Review in a General Medical Research Journal Before and During the COVID-19 PandemicRoy H Perlis, Jacob Kendall-Taylor, Kamber Hart, et al.
Clinical Pharmacology and Therapeutics|June 21, 2020
Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral NeuropathyKatherina C Chua, Chenling Xiong, Carol Ho, et al.
BMC Cancer|January 26, 2025
The association of travel distance and other patient characteristics with breast cancer stage at diagnosis and treatment completion at a rural Rwandan cancer facilityKayleigh Bhangdia, Abirami Natarajan, Niclas Rudolfson, et al.
JAMA Oncology|January 12, 2023
Long-term Effect of Machine Learning-Triggered Behavioral Nudges on Serious Illness Conversations and End-of-Life Outcomes Among Patients With Cancer: A Randomized Clinical TrialChristopher R Manz, Yichen Zhang, Kan Chen, et al.
BMC Cancer|March 20, 2016
Pursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural RwandaNeo M Tapela, Tharcisse Mpunga, Bethany Hedt-Gauthier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2012
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101R Michael Baldwin, Kouros Owzar, Hitoshi Zembutsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated dailyJoseph P Eder, Jeffrey G Supko, Jeffrey W Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2012
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathyHeather E Wheeler, Eric R Gamazon, Claudia Wing, et al.
Frontiers in Oncology|December 6, 2014
The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countriesC Norman Coleman, Silvia C Formenti, Tim R Williams, et al.
The Pharmacogenomics Journal|February 12, 2014
Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance)A Chhibber, J Mefford, E A Stahl, et al.
Pageof 29

Showing results (251-260 of 282) with videos related to

Sort By:
Pageof 29
JAMA Network Open|January 27, 2023
Peer Review in a General Medical Research Journal Before and During the COVID-19 PandemicRoy H Perlis, Jacob Kendall-Taylor, Kamber Hart, et al.
Clinical Pharmacology and Therapeutics|June 21, 2020
Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral NeuropathyKatherina C Chua, Chenling Xiong, Carol Ho, et al.
BMC Cancer|January 26, 2025
The association of travel distance and other patient characteristics with breast cancer stage at diagnosis and treatment completion at a rural Rwandan cancer facilityKayleigh Bhangdia, Abirami Natarajan, Niclas Rudolfson, et al.
JAMA Oncology|January 12, 2023
Long-term Effect of Machine Learning-Triggered Behavioral Nudges on Serious Illness Conversations and End-of-Life Outcomes Among Patients With Cancer: A Randomized Clinical TrialChristopher R Manz, Yichen Zhang, Kan Chen, et al.
BMC Cancer|March 20, 2016
Pursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural RwandaNeo M Tapela, Tharcisse Mpunga, Bethany Hedt-Gauthier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2012
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101R Michael Baldwin, Kouros Owzar, Hitoshi Zembutsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated dailyJoseph P Eder, Jeffrey G Supko, Jeffrey W Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2012
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathyHeather E Wheeler, Eric R Gamazon, Claudia Wing, et al.
Frontiers in Oncology|December 6, 2014
The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countriesC Norman Coleman, Silvia C Formenti, Tim R Williams, et al.
The Pharmacogenomics Journal|February 12, 2014
Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance)A Chhibber, J Mefford, E A Stahl, et al.
Pageof 29